CAS 1051387-90-6

SPI112

CAS : 1051387-90-6

Formule : C₂₂H₁₇FN₄O₅S

Degré de pureté : 96%

Couleur et forme : Solid

Masse moléculaire : 468.4576

Ref: IN-DA01DU9Z

(Z)-3-(2-(5-(N-(4-Fluorobenzyl)Sulfamoyl)-2-Oxoindolin-3-Ylidene)Hydrazinyl)Benzoic Acid

CAS : 1051387-90-6

(Z)-3-(2-(5-(N-(4-Fluorobenzyl)Sulfamoyl)-2-Oxoindolin-3-Ylidene)Hydrazinyl)Benzoic Acid

Degré de pureté : 98%

Masse moléculaire : 468.46g/mol

Ref: 54-PC108431

SPI-112

CAS : 1051387-90-6

SPI-112

Degré de pureté : ≥95%

Masse moléculaire : 468.46g/mol

Ref: 54-BUP14351

SPI-112

CAS : 1051387-90-6

SPI-112, the SPI-112 methyl ester analog, can inhibit cellular Shp2 PTP activity.

Formule : C₂₂H₁₇FN₄O₅S

Degré de pureté : 97.51% - >99.99%

Couleur et forme : Solid

Masse moléculaire : 468.46

Ref: TM-T4340

SPI 112

CAS : 1051387-90-6

SPI 112 is a small molecule that inhibits the enzyme phosphatase. SPI 112 has been shown to be effective in mouse tumor models, and it has been found to inhibit growth factor-stimulated cell proliferation. This compound binds to the active site of the phosphatase and dephosphorylates the substrate protein. SPI 112 also inhibits epidermal growth factor (EGF) and interferon alfa-2b induced DNA synthesis in fetal bovine cells. It is not yet known if this drug has any effect on cancer cells grown in culture or radiation-induced apoptosis in human breast cancer cells.

Formule : C₂₂H₁₇FN₄O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 468.46 g/mol

Ref: 3D-BSB38790